Browsing Tag
United States Patent and Trademark Office
2 posts
NeuroSense Therapeutics (NASDAQ: NRSN) extends PrimeC exclusivity to 2042 with Australian patent as Phase 3 focus intensifies
Find out how NeuroSense Therapeutics’ Australian patent grant strengthens PrimeC’s long-term outlook as the ALS program advances toward Phase 3.
PhotonPharma secures U.S. patent for cancer immunotherapy technology with potential to reshape ovarian cancer treatment
PhotonPharma secures U.S. patent for Innocell cancer vaccine tech, targeting ovarian cancer with scalable immunotherapy. See how it could reshape oncology.